Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in CKD patients with secondary hyperparathyroidism not on dialysis
NCT00094484Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Oct 2004; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00094484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094484.